PCM
DVAX

Peregrine Capital Management’s Dynavax Technologies DVAX Stock Holding History

Peregrine Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-671,231
Closed -$6.67M – 312
2025
Q3 		$6.67M Sell
671,231
-17,665
-3% -$184K 0.2% 142
2025
Q2 		$6.83M Buy
688,896
+11,878
+2% +$125K 0.21% 139
2025
Q1 		$8.78M Buy
677,018
+22,398
+3% +$296K 0.29% 82
2024
Q4 		$8.36M Buy
654,620
+11,687
+2% +$141K 0.25% 108
2024
Q3 		$7.16M Buy
642,933
+108,479
+20% +$1.2M 0.22% 134
2024
Q2 		$6M Buy
534,454
+6,952
+1% +$80.9K 0.18% 203
2024
Q1 		$6.55M Buy
527,502
+168
+0% +$2.19K 0.19% 183
2023
Q4 		$7.37M Sell
527,334
-90,916
-15% -$1.26M 0.22% 158
2023
Q3 		$9.13M Buy
618,250
+57,342
+10% +$806K 0.27% 123
2023
Q2 		$7.25M Buy
+560,908
New +$6.39M 0.2% 213

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Peregrine Capital Management's DVAX Position: Q4 2025 in Review

Peregrine Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 671,231 shares — an estimated $6.67M sold.

Peregrine Capital Management first reported a position in DVAX in Q2 2023 and held it in 10 quarters. The position peaked at $9.13M in Q3 2023. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Peregrine Capital Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Peregrine Capital Management sold 671,231 Dynavax Technologies shares in Q4 2025, an estimated $6.67M.
  • Peregrine Capital Management first reported a position in Dynavax Technologies in Q2 2023 and held it in 10 quarters.
  • Peregrine Capital Management's Dynavax Technologies position peaked at $9.13M in Q3 2023.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Peregrine Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.